1. 2558 Impact of PTEN protein loss on response to docetaxel and overall survival (OS) in metastatic castration resistant prostate cancer (mCRPC) patients. (September 2015) Authors: Rescigno, P.; Lorente, D.; Bianchini, D.; Kolinsky, M.; Zafeiriou, Z.; Ferraldeschi, R.; Mateo, J.; Recine, F.; Jayaram, A.; Nava Rodrigues, D.; Riisnaes, R.; Miranda, S.; Figueiredo, I.; Crespo, M.; Mehra, N.; Perez-Lopez, R.; Tunariu, N.; Reid, A.; Attard, G.; De Bono, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S496 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗